In the absence of sales data and forecasts guidance, I can only note that the execution of the strategy is exactly as stated at launch. No hard selling, just being out there in the cyber world, being the first point of call for all asthma related news/ articles/ pollen counts etc. Also doind deals with distributors without actually needing them.
I sense a confidence that can be explained by two factors
a) wanting no customer satisfaction stuff ups.
b) sales going to plan.
No boots and all sales by whatever means.
When this company announces that its sales figures are covering costs (by my rough estimates before US launch), most people will be wondering why it is nearing $1B in capitalisation.
Add to My Watchlist
What is My Watchlist?